A Synthetic Hybrid Molecule for the Selective Removal of Human Pluripotent Stem Cells from Cell Mixtures (混合細胞サンプルからヒト多能性幹細胞を選択的に除去する合成ハイブリッ ド化合物) （論文内容の要旨）
Human induced pluripotent stem cells (hiPSCs) serve as highly valuable resources both for basic research and regeneration therapy. Despite the advantages, however, there are still a number of problems that limit the clinical application. One of them is a tumorigenic risk of undifferentiated cells during transplantation. For safer transplantation, it is necessary to eliminate the undifferentiated cells selectively.
Kyoto probe 1 (KP-1), a fluorescent molecule that selectively labels hiPSCs, was previous discovered. Mechanistic study showed that its selectivity results primarily from a distinct expression pattern of ABC transporters in human pluripotent stem cells and from the transporter selectivity of KP-1. Expression of ABCB1 (MDR1) and ABCG2 (BCRP), both of which cause the efflux of KP-1, is repressed in human pluripotent stem cells.
The mechanism of KP-1 allowed two strategies to eliminate hiPSCs selectively. In one approach, a chemical library of cytotoxic molecules was screened and compound 185 was found to be a substrate both for ABCB1 and ABCG2. This okadaic acid derivative selectively eliminated hiPSCs from cell mixtures. However, clinical application of this marine natural product derivative was hampered by its moderate selectivity, limited supply, and low chemical tractability. The other approach was direct conjugation of KP-1 with cytotoxic anticancer drugs. Among the synthetic KP-1-drug conjugates, an exceptionally selective, chemically tractable molecule was found to induce death of hiPSCs. Mechanistic analysis suggested that the high selectivity originates from a synergistic combination of the transporter-mediated efflux and the mode of cytotoxicity action. The present research offers a chemical and mechanistic rationale for designing selective, safe, and simple reagents for preparation of non-tumorigenic clinical samples. 
